Kalbe Farma Tbk PT (KLBF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Kalbe Farma Tbk PT (KLBF) has a cash flow conversion efficiency ratio of 0.040x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp956.75 Billion ≈ $56.06 Million USD) by net assets (Rp24.19 Trillion ≈ $1.42 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See KLBF defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Kalbe Farma Tbk PT - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how Kalbe Farma Tbk PT's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Kalbe Farma Tbk PT Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kalbe Farma Tbk PT ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Snowline Gold Corp.
V:SGD
|
N/A |
|
Entra ASA
OL:ENTRA
|
0.054x |
|
Syngene International Limited
NSE:SYNGENE
|
-0.010x |
|
Shandong Gettop Acoustic Co Ltd
SHE:002655
|
-0.031x |
|
Xiamen Leading Optics Co Ltd
SHG:605118
|
0.047x |
|
Soulbrain Co. Ltd
KQ:357780
|
0.047x |
|
WeRide Inc. American Depositary Shares
NASDAQ:WRD
|
0.022x |
|
HCI Group Inc
NYSE:HCI
|
0.168x |
Annual Cash Flow Conversion Efficiency for Kalbe Farma Tbk PT (2000–2024)
The table below shows the annual cash flow conversion efficiency of Kalbe Farma Tbk PT from 2000 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Kalbe Farma Tbk PT.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp24.59 Trillion ≈ $1.44 Billion |
Rp4.79 Trillion ≈ $280.39 Million |
0.195x | +54.74% |
| 2023-12-31 | Rp23.12 Trillion ≈ $1.35 Billion |
Rp2.91 Trillion ≈ $170.37 Million |
0.126x | -26.28% |
| 2022-12-31 | Rp22.10 Trillion ≈ $1.29 Billion |
Rp3.77 Trillion ≈ $220.87 Million |
0.171x | +28.37% |
| 2021-12-31 | Rp21.27 Trillion ≈ $1.25 Billion |
Rp2.83 Trillion ≈ $165.59 Million |
0.133x | -42.38% |
| 2020-12-31 | Rp18.28 Trillion ≈ $1.07 Billion |
Rp4.21 Trillion ≈ $246.97 Million |
0.231x | +53.92% |
| 2019-12-31 | Rp16.71 Trillion ≈ $978.88 Million |
Rp2.50 Trillion ≈ $146.66 Million |
0.150x | -17.30% |
| 2018-12-31 | Rp15.29 Trillion ≈ $896.20 Million |
Rp2.77 Trillion ≈ $162.36 Million |
0.181x | +25.33% |
| 2017-12-31 | Rp13.89 Trillion ≈ $814.14 Million |
Rp2.01 Trillion ≈ $117.68 Million |
0.145x | -16.59% |
| 2016-12-31 | Rp12.46 Trillion ≈ $730.33 Million |
Rp2.16 Trillion ≈ $126.56 Million |
0.173x | -22.85% |
| 2015-12-31 | Rp10.94 Trillion ≈ $640.94 Million |
Rp2.46 Trillion ≈ $143.97 Million |
0.225x | -4.79% |
| 2014-12-31 | Rp9.82 Trillion ≈ $575.27 Million |
Rp2.32 Trillion ≈ $135.72 Million |
0.236x | +116.28% |
| 2013-12-31 | Rp8.50 Trillion ≈ $498.06 Million |
Rp927.16 Billion ≈ $54.33 Million |
0.109x | -41.58% |
| 2012-12-31 | Rp7.37 Trillion ≈ $431.95 Million |
Rp1.38 Trillion ≈ $80.65 Million |
0.187x | -17.44% |
| 2011-12-31 | Rp6.52 Trillion ≈ $381.81 Million |
Rp1.47 Trillion ≈ $86.34 Million |
0.226x | +13.15% |
| 2010-12-31 | Rp5.77 Trillion ≈ $338.21 Million |
Rp1.15 Trillion ≈ $67.60 Million |
0.200x | -29.78% |
| 2009-12-31 | Rp4.79 Trillion ≈ $280.71 Million |
Rp1.36 Trillion ≈ $79.90 Million |
0.285x | +53.10% |
| 2008-12-31 | Rp4.34 Trillion ≈ $254.57 Million |
Rp807.70 Billion ≈ $47.33 Million |
0.186x | +105.77% |
| 2007-12-31 | Rp4.02 Trillion ≈ $235.36 Million |
Rp362.90 Billion ≈ $21.26 Million |
0.090x | -50.02% |
| 2006-12-31 | Rp3.54 Trillion ≈ $207.67 Million |
Rp640.61 Billion ≈ $37.54 Million |
0.181x | +15.14% |
| 2005-12-31 | Rp2.81 Trillion ≈ $164.74 Million |
Rp441.37 Billion ≈ $25.86 Million |
0.157x | -45.36% |
| 2004-12-31 | Rp1.48 Trillion ≈ $86.69 Million |
Rp425.07 Billion ≈ $24.91 Million |
0.287x | -42.02% |
| 2003-12-31 | Rp1.02 Trillion ≈ $59.97 Million |
Rp507.17 Billion ≈ $29.72 Million |
0.496x | -19.13% |
| 2002-12-31 | Rp651.41 Billion ≈ $38.17 Million |
Rp399.13 Billion ≈ $23.39 Million |
0.613x | +25.47% |
| 2001-12-31 | Rp345.97 Billion ≈ $20.27 Million |
Rp168.95 Billion ≈ $9.90 Million |
0.488x | +52.08% |
| 2000-12-31 | Rp305.74 Billion ≈ $17.91 Million |
Rp98.17 Billion ≈ $5.75 Million |
0.321x | -- |
About Kalbe Farma Tbk PT
PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biop… Read more